Radiology, Vol 205, 173-180, Copyright © 1997 by Radiological Society of North America

ARTICLES

Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt

GK Nazarian, H Bjarnason, CA Dietz Jr, CA Bernadas, MC Foshager, H Ferral and DW Hunter
Department of Radiology, University of Minnesota School of Medicine, Minneapolis 55455-0391, USA.

PURPOSE: To assess midterm results and examine factors associated with successful treatment of refractory ascites with creation of a transjugular intrahepatic portosystemic shunt (TIPS). MATERIALS AND METHODS: In 50 patients with refractory ascites, TIPS creation was performed. Clinical and ultrasound follow-up were performed. Success was defined as survival with no further therapeutic paracentesis and decreased ascites. RESULTS: Mean follow-up was 11.6 months after the TIPS procedure. Major complications occurred in 16% of patients including intraperitoneal hemorrhage, refractory encephalopathy, and progression of liver and renal failure. Overall mortality was 60% (30 patients). In 23 (62%) of 37 patients not lost to follow-up, ascites was controlled successfully at 1-3 months. A bilirubin level greater than 3.0 mg/dL (52 mumol/L) and creatinine level greater than 1.9 mg/dL (170 mumol/L) were associated with treatment failure (86% treatment failure at 3 months) and early mortality (P = .03). In all 14 patients alive at 1-year follow-up, ascites was controlled successfully. CONCLUSION: TIPS creation is often useful in treatment of severe ascites not controlled with medical therapy. In patients with advanced liver and renal failure, TIPS creation is not associated with a definite benefit and may hasten death.

This article has been cited by other articles:

				K P Moore and G P Aithal Guidelines on the management of ascites in cirrhosis Gut, October 1, 2006; 55(suppl_6): vi1 - vi12. [Full Text] [PDF]

				T. G. Van Ha, B. S. Funaki, J. Ehrhardt, J. Lorenz, D. Cronin, J. M. Millis, and J. Leef Transjugular Intrahepatic Portosystemic Shunt Placement in Liver Transplant Recipients: Experiences with Pediatric and Adult Patients Am. J. Roentgenol., March 1, 2005; 184(3): 920 - 925. [Abstract] [Full Text] [PDF]

				H. Suzuki and A.J. Stanley Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome QJM, June 1, 2001; 94(6): 293 - 300. [Abstract] [Full Text] [PDF]

				S. M. Daves The Liver and Vascular Surgery Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 275 - 288. [Abstract] [PDF]

				M. Rossle, A. Ochs, V. Gulberg, V. Siegerstetter, J. Holl, P. Deibert, M. Olschewski, M. Reiser, and A. L. Gerbes A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites N. Engl. J. Med., June 8, 2000; 342(23): 1701 - 1707. [Abstract] [Full Text] [PDF]

				J. R. Lake The Role of Transjugular Portosystemic Shunting in Patients with Ascites N. Engl. J. Med., June 8, 2000; 342(23): 1745 - 1747. [Full Text]

				R JALAN, H F LUI, D N REDHEAD, and P C HAYES TIPSS 10 years on Gut, April 1, 2000; 46(4): 578 - 581. [Full Text] [PDF]